TITLE

The Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells and Simvastatin in a Rat Model of Liver Fibrosis

AUTHOR(S)
Motawi, Tarek; Atta, Hazem; Sadik, Nermin; Azzam, May
PUB. DATE
January 2014
SOURCE
Cell Biochemistry & Biophysics;Jan2014, Vol. 68 Issue 1, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Liver fibrosis is the excessive accumulation of extracellular matrix (ECM) proteins including collagen that occurs in most types of chronic liver diseases. Studies concerning the capacity of mesenchymal stem cells (MSCs) and simvasatain (SIMV) to repair fibrotic tissues through reducing inflammation, collagen deposition, are still controversial. This study aimed to investigate the therapeutic efficacy of bone marrow (BM)-derived MSCs and SIMV on carbon tetrachloride (CCl)-induced liver fibrosis in rats. Rats were divided into: normal, CCl, CCl/MSCs, CCl/SIMV, CCl/MSCs/SIMV, and SIMV groups. BM-derived MSCs were detected by RT-PCR of CD29 and were then infused into the tail vein of female rats that received CCl injection to induce liver fibrosis. Sex-determining region Y (SRY) gene on Y-chromosome gene was assessed by PCR to confirm homing of the male stem cells in liver tissue of the female recipients. Serum liver function tests, liver procollagens I and III, tissue inhibitors of metalloproteinase-1 (TIMP-1), endoglin, matrix metalloproteinase-1 (MMP-1) gene expressions, transforming growth factor-beta (TGF-β1) immunostaining, and histopathologicl examination were performed. MSCs and SIMV decreased liver procollagens I and III, TIMP-1 and endoglin gene expressions, TGF-β1 immunostaining, and serum liver function tests compared with the CCl group. MMP-1 expression was increased in the CCl/MSCs group. Histopathological examination as well as fibrosis score supports the biochemical and molecular findings. It can be concluded that MSCs and SIMV were effective in the treatment of hepatic CCl-induced fibrosis-rat model. Treatment with MSCs was superior to SIMV. This antifibrotic effect can be attributed to their effect on the MMPs/TIMPs balance which is central in fibrogenesis.
ACCESSION #
93437864

 

Related Articles

  • Fetal membranes as a source of stem cells. Kmiecik, G.; Niklińska, W.; Kuć, P.; Pancewicz-Wojtkiewicz, J.; Fil, D.; Karwowska, A.; Karczewski, J.; Mackiewicz, Z. // Advances in Medical Sciences (De Gruyter Open);2013, Vol. 58 Issue 2, p185 

    In recent years, a constant growth of knowledge and clinical applications of stem cells have been observed. Mesenchymal stromal cells, also described as mesenchymal stem cells (MSCs) represent a particular cell type for research and therapy because of their ability to differentiate into...

  • Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Plock, Jan A.; Schnider, Jonas T.; Schweizer, Riccardo; Gorantla, Vijay S.; Bondanza, Attilio; Biagi, Ettore // Frontiers in Immunology;Feb2013, Vol. 4, Special section p1 

    The article discusses a study by E. Eggenhofer and colleagues published in an issue of "Frontiers in Immunology" on the role of cultured mesenchymal stromal cells (MSCs) in immunomodulation in transplantation. The researchers presented evidence in a mouse model that cultured bone-marrow derived...

  • Hydrodynamic loading in concomitance with exogenous cytokine stimulation modulates differentiation of bovine mesenchymal stem cells towards osteochondral lineages. Goldman, Stephen M.; Barabino, Gilda A. // BMC Biotechnology;2/1/2016, Vol. 16, p1 

    Background: Mesenchymal stem cells (MSCs) are viewed as a having significant potential for tissue engineering and regenerative medicine therapies. Clinical implementation of MSCs, however, demands that their preparation be stable and reproducible. Given that environmental and bioprocessing...

  • Proteomic analysis of the impact of static culturing on the expansion of rat bone marrow mesenchymal stem cells. Peter, Stefan; Evans, Caroline; Ow, Saw; Scutt, Andy; Wright, Phillip; Biggs, Catherine // Biotechnology Letters;Aug2012, Vol. 34 Issue 8, p1589 

    The clinical potential of mesenchymal stem cells (MSC) in tissue engineering and regenerative medicine is due to their self-renewal, proliferation and multi-lineage differentiation potential. Clinical use requires large cell numbers; which can, theoretically, be generated by ex vivo expansion of...

  • Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children. Autologous MSCs may be a better cell source and have been studied for the treatment of cerebral palsy because of...

  • Effect of nuclear receptor corepressor on bone marrow mesenchymal stem cells proliferation. Hongwei Gao; Deguo Xing; Liang Wang; Lan Liu; Zhonghao Liu; Mingzhi Gong // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p13965 

    Objective: Bone marrow mesenchymal stem cells (BMSCs) are considered a promising cell source for tissue engineering. Methods to advance the proliferation and anti-apoptotic capacity of mesenchymal stem cells (MSCs) are required to improve the efficiency of MSC-based therapy. In this study, we...

  • Cell therapy for cerebral hemorrhage: Five year follow-up report. ZHITIAN CHANG; GENGSHENG MAO; LIZHONG SUN; QIANG AO; YONGQUAN GU; YING LIU // Experimental & Therapeutic Medicine;Dec2016, Vol. 12 Issue 6, p3535 

    The aim of the study was to examine treatment of cerebral hemorrhages with bone-marrow or human umbilical cord-derived mesenchymal stem cells (BMSCs or Hu-MSCs) and conventional surgical approaches, and determine and compare the effectiveness, feasibility, safety and reproducibility of each...

  • Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study. Giordano, Rosaria; Canesi, Margherita; Isalberti, Maurizio; Isaias, Ioannis Ugo; Montemurro, Tiziana; Viganò, Mariele; Montelatici, Elisa; Boldrìn, Valentina; Benti, Riccardo; Cortelezzi, Agostino; Fracchiolla, Nicola; Lazzari, Lorenza; Pezzoli, Gianni // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p1 

    Background Progressive Supranuclear Palsy (PSP) is a sporadic and progressive neurodegenerative disease which belongs to the family of taupathies and involves both cortical and subcortical structures. No effective therapy is to date available. Methods/design Autologous bone marrow (BM)...

  • Structural investigation of donor age effect on human bone marrow mesenchymal stem cells: FTIR spectroscopy and imaging. Aksoy, Ceren; Kaya, Fatima; Kuşkonmaz, Bülent; Uçkan, Duygu; Severcan, Feride // Age;Aug2014, Vol. 36 Issue 4, p1 

    Stem cell studies hold enormous potential for development of new therapies for tissue regeneration and repair. Bone marrow mesenchymal stem cells (BM-MSCs) can differentiate into a variety of non-hematopoietic tissues and contribute maintenance of healthy hematopoiesis by providing supportive...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics